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The valid extrapolation of carcinogenesis data from one species to another depends, in part, on strong
similarities ofthe metabolic and cellular mechanisms involved in the carcinogenic process and similarities
in the nature and behavior ofthe various lesions that appearduring the development ofneoplasia between
the species involved. Although there are many biological differences between the various rodent species
used in carcinogenesis research, there are more similarities, in keeping with the surprising unity ofbasic
cellular and tissue organization and function that is evident throughout biological systems at every level
of evolutionary development. An understanding of intraspecies similarities and differences, especially as
these modify the morphologic responses of the host to carcinogenic chemicals, is of central importance
if carcinogenesis data from one species are to be used to predict carcinogenic risk in another. In this
manuscript the histopathology ofthe various lesions that appear during chemically induced cancer ofthe
liver, pancreas, and bladder in several rodentspecies has been selectedtocompare andcontrast similarities
and differences that exist among them and among the spontaneous premalignant lesions and carcinomas
of these organs in humans.
Process of Chemical
Carcinogenesis
Numerous studies have established that foreign com-
pounds, including chemical carcinogens, are handled in
a strikingly similar way by a wide variety of animal
species, including lower vertebrates and certain inver-
tebrates (1). Thegeneralpatternbywhichthe organism
protects itself from potentially noxious substances,
many of which are lipophilic and enter cells, involves
their metabolic conversion to more polar and more
water-soluble metabolites, which are rapidly excreted.
This property ofcells, especially those at the portals of
entry into the body, affords the organism an advantage
for surviving in a hostile environment. This protective
phenomenon is not foolproof, because during the bio-
transformation of certain chemicals, metabolites are
formed that are highly reactive and toxic to the cell. In
some cases, thehostconverts achemicalcarcinogen that
in its original form is nontoxic and noncarcinogenic to
a form that is both toxic and carcinogenic.
Present dogma holds that DNA is the intracellular
target molecule with which highly reactive metabolites
ofcarcinogens react. This causes either serious physical
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distortion of the DNA double helix by intercalation of
planar molecules, such as aromatic amines and poly-
cyclic hydrocarbons, or base substitution through al-
kylation by alkyl nitrosamines or nitrosamides. Ifthese
defects are not removed and repaired before the DNA
is replicated, they are amplified and become fixed and
persist through the replication process. This earliest
recognized stage of carcinogenesis, designated as ini-
tiation, is consideredtooccurrapidlyandtobeheritable
and irreversible. A significant property ofinitiated cells
that has been identified in the past several years is that
initiated cells acquire resistance to the cytotoxic and
cytostatic effects of chemical carcinogens. This is due
to a decrease in the intracellular levels ofthe enzymes
responsible for the metabolic activation of carcinogens
and a concomitant increase in the levels of those re-
sponsible for detoxification by conjugation and esteri-
fication (2). Thus, initiated cells have undergone adap-
tations that allow them to proliferate during continued
exposure to a carcinogen while their adjacent, nonini-
tiated counterparts are growth-inhibited, or, if suffi-
ciently injured by toxic metabolites, these noninitiated
cells ultimately die. The death of noninitiated, lethally
damaged cells serves as a potent stimulus for compen-
satory growth, which leads to selective growth of the
initiated cells, a phenomenon designated as clonal se-
lection (3). The expansion of initiated cell populationsD. G. SCARPELLI
gives rise to islands, foci, and nodules ofcells that show
phenotypic differences as compared to noninitiated
cells. While most ofthese early eventsincarcinogenesis
were identified and documented from studies ofexper-
imental liver carcinogenesis in rats (3-5), preliminary
evidence suggests that they probably also occur during
carcinogenesis in other organs as well, although this
remains to be established unequivocally.
The transformation of initiated cells with the phen-
otypic and biological characteristics of neoplasia that
occurs during a second, more protracted, stage of car-
cinogenesis is designated as promotion (3,6). This is
much less well understood than initiation and remains
a prime facet of contemporary research on carcinogen-
esis. Promotion is mediated by exposure ofthe host to
a diverse group of substances, which include weak
chemical carcinogens, low levels ofpotent carcinogens,
growth factors, hormones, polyunsaturated fats in the
diet, and certain noncarcinogenic compounds such as
phenobarbital. The sequence ofexposure to promoters
is important, as they are effective only if encountered
afterinitiation has occurred. While the mechanism(s) of
promotion are complex and remain to be elucidated,
severalgeneraleffectscommontomanypromotershave
been identified, namely, the stimulation of cell growth
or the modulation of differentiation, or for some pro-
moters, both effects have been identified. Promotion,
like initiation, has been documented to be operative
duringcarcinogenesis inavarietyoforganssuchasskin,
lung, liver, pancreas, gastrointestinaltract, kidney, and
urinary bladder. The general process ofcarcinogenesis
is shown in Figure 1.
Some Interspecies Comparisons of
Chemical Carcinogenesis
Hepatocarcinogenesis
Since the rodent liver, especially that of the mouse
and rat, is susceptible to a variety of chemical carcin-
ogens administered by diet or injected IP, it is impor-
tant to compare and contrast the variety of prolifera-
tive, preneoplastic, and neoplastic lesions that develop
in the two species. Although the mouse is widely used
in chemical carcinogenesis research and testing, it has
not been the species of choice for experimental liver
carcinogenesis experiments. In part, this may be ex-
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FIGURE 2. An island of altered hepatocytes in rat liver following a
single exposure to diethylnitrosamine (DEN). Note the absence
of compression of adjacent normal liver cells. H& E, x 400.
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FIGURE 1. Schematic representation of the general process of car-
cinogenesis.
FIGURE 3. An early hepatic nodule in the rat showing marked cy-
tologic abnormalities of liver cells and compression of adjacent
normal liver indicating its proliferative capacity. H & E, x 355.
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FIGURE 5. Basophilic nodule in mouse liver following a single dose
FIGURE 4. DEN-induced hepatocellular carcinoma in the rat char- of DEN administered at 15 days of age. H & E, x 150.
acterized by a disorganized tissue architecture, cellular atypia,
and numerous cells in mitosis. H&E, x 400.
Table 1. Histochemical properties ofdiethylnitrosamine-induced
foci in mouse and rat liver.
Histochemical marker Mouse Rat
Adenosine triphosphatase I Cytoplasmic t Membrane bound
t Membrane bound
Acid phosphatase
Glucose-6-phosphatase l
Glucose phosphate t
dehydrogenase
y-Glutamyl No change a
transpeptidase
Periodic acid Schiff
reaction
aAppears to be related to the carcinogen employed.
Table 2. Lesions induced by carcinogens in mouse and rat liver.
Lesion Mouse Rat
Clear cell Rare +
Glycogen storage ? +
Basophilic + +
Basophilic nodule with vascular +
invasion
Acidophilic Rare
Megalocytosis Rare +
Hyperplastic + +
Neoplastic + +
Carcinoma + +
plained by the finding some years ago that inbred mice,
especiallythe C3H and CBAstrains, areproneto ahigh
incidence of spontaneous hepatic tumors, including he-
patocellular carcinoma (7). Strain C57BL mice, on the
other hand, as well as crosses with C3H, have a low
hepatic tumor incidence and are used in studies involv-
ing hepatocarcinogenesis. Grasso and Crampton (8)
questioned the validity ofthe mouse as an animalmodel
forcarcinogenesis studies and the bioassay ofchemicals
on the grounds that its responses to carcinogens differ
significantly from those of the rat and other mammals.
This notion was later refuted in a carefully annotated
survey of the literature reporting results from labora-
tories worldwide (9), which documented that the re-
sponses of mouse liver and other organs to hepatic mi-
crosomal enzyme inducers and chemical carcinogens are
not unique. These responses include the development
of tumors, and in many instances, are similar to those
seen in other rodents such as the rat and hamster.
Chronic exposure of both the mouse and rat to he-
patocarcinogens leads to the development ofa spectrum
of lesions ranging from foci of phenotypically altered
hepatocytes with little or no evidence of augmented
growth, to those forming nodules due to enhanced
growth, and finally to hepatocellular carcinomas with
all of the cytologic and biological attributes of malig-
nancy (Figs. 2-5). In the rat, the development ofchem-
ically induced liver cancer has been studied in consid-
erable detail (3,4). The early morphologic alterations of
liver cells include increased eosinophilia orbasophilia of
the cytoplasm, and cytoplasmic accumulation ofneutral
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fat or glycogen that gives rise to clear cells. Early le-
sions consist ofcells with minimal cytologic changes; as
these progress, they show histochemical, biochemical,
and cytologic features that differ significantly from
those ofnormal liver cells.
More recently, these lesions have also been identified
intheearlystagesofdiethylnitrosamine (DEN)-induced
hepatocellular carcinogenesis in B6C3F1 mice (10). The
histochemical patterns of such foci in mouse liver are
similar to those in the rat, with a few exceptions, such
as ATPase and -y-glutamyltranspeptidase, forwhichthe
pathogenetic significance is not understood. These are
compared and summarized in Table 1. As foci assume
greater autonomy from host growth control factors,
they grow into nodules that compress adjacent liver
cells. More oftenthan not, the livercellsin suchnodules
showcytologic changes associatedwithmalignancy such
as large hyperchromatic nuclei and nucleoli and in-
creased numbers of cells in mitosis. Nodules are class-
ified as hyperplastic or neoplastic, depending on the
extent to which liver cell morphology and liver tissue
organization differ from normal. These nodules are fol-
lowed by the appearance of nodules with all the mor-
phologic and biologic features of liver cell cancer. The
varioustypesoflesions inducedbycarcinogensinmouse
and rat liver are compared in Table 2.
The salient difference between the two species is that
lesions in the mouse tend, in general, to be more well-
differentiated than those in the rat. This species differ-
ence may make the morphological distinction between
nonneoplastic and neoplastic liverinthe mouse difficult,
and has caused much confusion and controversy, until
it was established that some hepatocarcinomas that
were almost indistinguishable from nonneoplastic hy-
perplastic lesions were indeed capable ofmetastases to
distant sites such as the lung. Similar difficulties were
encountered in a recent study that attempted to assess
the potential of the various types ofbenign and malig-
nant spontaneous hepatic nodules in B6C3F1 mice and
those induced by a chlorinated hydrocarbonpesticide to
grow following their transplantation into syngeneic
hosts. It was concluded that morphology alone was not
adequate for predictingthe capacity ofmouse liver nod-
ules for autonomous growth (11).
An interesting property of basophilic nodules in the
mouse that differs from similar lesions inthe rat is their
capacity to invade adjacent intrahepatic blood vessels
(Fig. 6). This finding, which has been interpreted as
evidence ofmalignant behavior (12), is curious because
it is often encountered in small foci and nodules early
in the carcinogenic process and is much less frequent,
and often absent, in much larger nodules in the later
stages of cancer development. This finding is counter
to what one would expect ifpermeation ofintrahepatic
blood vessels in the mouse were indeed a reflection of
malignancy. Its biological significance remains unclear.
The pathogenesis andhistopathology ofexperimental
liver cancer in rodents are strikingly similar to human
hepatocellular carcinoma in many respects. In contrast
to the rat and mouse, cirrhosis is a frequent precursor
FIGURE 6. Anintravascular extension ofbasophilic hepatocytes (ar-
row) in mouse liver exposed to DEN. H&E, x 220.
concomitant to hepatocellular carcinoma inman (13,14).
Focal liver cell nodules showing phenotypic alterations
and augmented growth have been identified as precur-
sors to the development ofliver cell cancer in humans,
although it has not beenpossible to study these as thor-
oughly as those induced in experimental animals. For
example, it has not yet been established that the his-
tochemical spectrum of lesions documented in the rat
and mouse also develops in humans. However, glyco-
gen-richlivercelllesions andcarcinomas havebeendoc-
umented in humans, as well as proliferative nodules
consisting ofmarkedly atypical cells, so-called liver cell
dysplasia. The status of liver cell adenomas in humans
appeared unclear (13); some years ago, when such le-
sions appeared in patients on oral contraceptives and
anabolic steroidmedication, itwas suggested thatthese
adenomas might represent antecedent lesions for he-
patocellular carcinoma. Our experience 10 years after
the emergence of adenomas in some patients on oral
contraceptives indicates that most ofthese do not prog-
ress tomalignancy and, infact, regress when suchmed-
ication is discontinued. It appears that spontaneous
hemorrhage is the predominant serious complication.
On the other hand, anabolic steroids, which enjoy wide
use among athletes, induce adenomas, some of which
have been documented to evolve to hepatocellular car-
cinomas.
There are many similarities between the morphol-
ogical aspects of chemically induced hepatocarcinoge-
nesis ofrodents and humans that suggest that they are
probably valid models for carcinogenesis testing. How-
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ever, difficulties in correlating the morphology of he-
patic nodules in the mouse with their biological behav-
ior, coupled with the apparent increased sensitivity of
mouse liver to chemical carcinogens, somewhat limits
the usefulness of hepatic nodules as models. The rat
model, on the other hand, suffers from none of these
problems and continues to be widely used for testing of
chemicals for their potential as hepatocarcinogens.
Pancreatic Carcinogenesis
An alarming and sustained increase in the incidence
ofpancreatic carcinoma in many parts ofthe world has
served as an impetus for the development of rodent
animal models to study its causes and pathogenesis. At
thepresent, Syriangoldenhamsters andratsarewidely
used experimentally (15,16) and have added signifi-
cantly to our understanding of pancreatic carcinogen-
esis. For reasons that are not immediately apparent,
different cells ofthe pancreas appear to be susceptible
targets to the chemicals that induce pancreatic cancer
in the two species. In the rat, a variety of carcinogens
[7,12-dimethylbenz[a]anthracene, 4-hydroxyaminoqui-
noline-l-oxide (4HAQO), azaserine, N5(N-methyl-N-ni-
trosocarbamoyl)L-ornithine, and certain hypolipidemic
drugs]induce carcinomas ofacinarcells, whichcomprise
about84% ofthecellsofthepancreas. Inhumans, acinar
cell carcinomas represent only 1% of all cases of pan-
creatic cancer. The major focus in this manuscript will
be on the pathogenesis and histopathology ofductal ad-
enocarcinoma in the hamster pancreas. In the hamster,
3-oxidized derivatives of N-nitrosodipropylamine in-
duce adenocarcinomas of the ducts, a cell that consti-
tutes less than 4% of the component cells of the pan-
creas. These neoplasms bear a close morphological and
biological resemblance to the most common type (96%
ofallcases) ofpancreatic cancerencountered inhumans.
This species difference in the histologic type of neo-
plasms induced by chemical carcinogenesis is ofconsid-
erable interest because the acinar cell in both species
is susceptible to carcinogens.
Acinar cell lesions in the rat begin as localized groups
of acini that undergo augmented growth and evolve
from microscopic foci to millimeter-sized nodules
(15,16), the larger of which are classified as adenomas.
The majority ofthese lesions consist oflarge acinarcells
packed with zymogen granules that are responsible for
their intense acidophilic staining with the hemotoxylin-
eosin staining (Fig. 7). Large nodules and adenomas
contain acinarcells with agreaterdegree ofnuclearand
nucleolar variability and are frequently not surrounded
by a connective tissue capsule. Acinar cell carcinomas
range from well-differentiated tumors comprised of
zymogen-granule-rich tumor cells to those in which the
neoplastic cells contain sparse granules (Fig. 8) or none
at all. In the latter, in vitro studies have shown that
these cells synthesize and secrete pancreatic enzymes,
suggesting that the absence of cytoplasmic granules is
probably due to a defect in the function of the Golgi
complex. Depending on the level ofdifferentiation, aci-
FIGURE 7. An acidophilic nodule (A) and a basophilic focus (B) in
rat pancreas following a single exposure to 4-hydroxyaminoqui-
noline-1-oxide. H &E, x 125.
FIGURE 8. Pancreatic acinar cell carcinoma induced by azaserine,
showing poorly defined acini and numerous dividing cells largely
lacking zymogen granules. H& E, x 280.
87D. G. SCARPELLI
nar cell carcinomas spread by local extension, invasion,
and distant metastases.
Two other acinar cell lesions include basophilic foci
and pseudoduct formation. Basophilic acinar cell foci
consist of cells that are largely depleted of zymogen
granules, have a low capacity for growth, and persist.
They are seen many months following exposure to a
carcinogen. Their biological significance remains un-
clear. An intriguing alteration of acini, which is often
seen in rats exposed to pancreatic carcinogens, consists
of their conversion to ductlike profiles referred to as
pseudoductules (17). Pseudoductules are formed by a
dilation ofacini and shedding ofthe apical cytoplasm of
the acinarcells so the ducts appearto be lined by acinar
cells containing variable numbers ofzymogen granules.
This alteration is considered an example of cell modu-
lation, as contrasted to true metaplasia where one cell
type is converted to another.
Detailed studies of the lesions induced in pancreatic
ductules andofthehamsterductsbyvariousderivatives
of,-oxidized-N-nitrosodipropylamine have documented
that the earliest changes involve a proliferation ofduc-
tules andapeculiar, permanenttransformationofacinar
cells to ductulelike profiles indistinguishable from
preexisting ones (15,16). This transformation is also ac-
companied by their augmented growth (Fig. 9). This
alteration of ductules was not unexpected since acinar
FIGURE 9. Pseudoductule formation from acinar cells in hamster
pancreas following chronic exposure to N-nitroso-bis-(2-oxopro-
pyl)amine (BOP). A near normal acinus showing slight dilation of
the lumen is shown at the lower right. The intense proliferative
activity ofacinar cells inthis lesion is documented by theiruptake
of3H-thymidine. H&E, x 395.
cells are part of the pancreatic duct system. However,
the permanent transformation was surprising and is a
very interesting facet ofpancreatic carcinogenesis. The
metaplastic transformation of one cell type to another
is an early precedent lesion documented in the patho-
genesis of squamous cell carcinoma of the bronchus,
uterine cervix, and more rarely, the urinary bladder.
Foci ofproliferating true ductules and ductules arising
from metaplastic acinar cells undergo dysplasia, malig-
nant transformation to carcinoma in situ, and invasive
adenocarcinoma. An alternate product of such foci in-
volves the formation ofdilated ductules and ducts lined
by cuboidal epithelium. Since the epithelium often in-
cludes acinar cells that have retained their capacity for
the synthesis ofzymogen granules, it is believed these
ducts arise from metaplastic acinar cells (Fig. 10). Such
ducts remain benign lesions that grow slowly to form
large complexes ofcystic ducts, which are classified as
cystadenomasandareoftenencounteredinanimalswith
invasive ductal adenocarcinoma. Larger ducts are also
thefocusofproliferative, dysplastic, preneoplastic, non-
invasive (Fig. 11), and invasive (Fig. 12) malignant ep-
ithelial lesions, although epithelial lesions appear to de-
velop later than lesions in ductules and metaplastic aci-
nar cells, suggesting that the epithelium of the large
ducts is somewhat less sensitive than that of ductules.
Carcinogen-induced lesions ofthe exocrine pancreata of
rat and hamster are compared in Table 3.
The metaplastic transformation of pancreatic acinar
FIGURE 10. Dilated ductules in hamster pancreas in which several
acinar cells (arrows) remain in the epithelial lining. These cells
identify their origin from pancreatic acini. H&E, x 400.
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FIGURE 11. A noninvasive intraductal adenocarcinoma in the pan-
creas of a hamster treated chronically with 1-oxidized-N-nitro-
sodipropylamine. H&E, x 240.
cells to ductules during the induction ofpancreatic duc-
tal adenocarcinoma in the hamster may have an equiv-
alent in the human pancreas. Studies ofnormal human
pancreata obtained at autopsy have identified ductal
transformation of acinar cells that appears to peak in
incidence duringthe sixth decade oflife andtobehigher
in cigarette smokers than in nonsmokers (18). More re-
cently, the demonstration of acinar cell metaplasia in
the nontumorous portion of pancreas from 16 cases of
pancreatic ductal adenocarcinoma raisesthe strongpos-
sibility that metaplasia may also be involved in human
pancreatic cancer (19). The foci of human acinar cell
metaplasiastainedintenselywithamonoclonalantibody
to asurface protein normally present only onpancreatic
duct epithelium. This is an example ofthe fidelity with
which acinar cells are transformed to ductular/ductal
epithelium. The foregoing examples are additional evi-
dence of the close similarities that exist between the
pancreatic tissues of the hamster and of man. This
should not be unexpected because it appears that cells
and tissues, regardless of species, have a limited rep-
ertoire ofadaptive responses to cellinjury and toxicity.
Carcinogenesis of Urinary Bladder
The lower urinary tract ofrodents extends from the
kidney pelvis through the ureters to the urinary blad-
der. It is lined by transitional epithelium (urothelium)
and is sensitive to a wide variety of chemical carcino-
gens. These carcinogens include 26 different amino and
FIGURE 12. An invasive pancreatic ductal adenocarcinoma in ham-
ster pancreas induced by N-nitroso-2,6-dimethylmorpholine.
H&E, x 155.
Table 3. A comparison of carcinogen-induced lesions in the
exocrine pancreas of rat and hamster.
Lesions
Acinar cell
Necrosis
Pseudoduct formation
(metaplasia)
Proliferation
Ductal complexes
Ductal cystadenomas
Basophilic foci
Acidophilic foci
Acidophillc nodules
Adenomas
Carcinomas
Rat
+
+
+
+
Hamster
+
Very rare
(mixed acinar-
ductal)
Duct cell
Proliferation
Metaplasia
Papilloma
Carcinoma in situ
Invasive adenocarcinoma
Islet cells
Intrainsular ductal metaplasia
vs. proliferation
+
+
+
+
+
+
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FIGURE 13. Transitional papilloma in the urinary bladder ofthe rat
chronically exposed to N-butyl-N-(4-hydroxybutyl)-nitrosamine
(BBN). H& E, x 195.
azo dyes, 6 nitrosamines, 6 nitroaryl compounds, and
at least 13 miscellaneous compounds, including phena-
cetin, saccharin, and cyclamate that have achieved con-
siderable notoriety. Since these compounds include im-
portant industrial chemicals, environmental pollutants,
food additives, bacterial metabolites, and medications,
the use of the rodent bladder as a model for the iden-
tification ofchemicals posing a risk for humans assumes
great significance. Thus, it is important to establish the
extent to which the pathogenesis of carcinoma of the
urinary bladder in the rat resembles the process in hu-
mans (20,21). As is true for other experimental carcin-
ogenesis models, much is known about the earliest le-
sions that develop during bladder carcinogenesis in the
rat, as contrasted to the situation in humans where
there is a paucity of information about the very early
lesions because patients are usually asymptomatic at
this stage oftheir disease and are not biopsied.
Simple hyperplasia is the earliest response ofurothe-
lium to exposure to carcinogens; this leads to cell rep-
lication with an increase ofepithelial thickness consist-
ing of four or more cell layers and no alteration of cell
maturation. With continued exposure, these changes
evolve to nodular and papillary hyperplasia, papilloma
(Fig. 13), and noninvasive carcinoma. Some simple, no-
dular, and papillary hyperplasias regress and the uro-
thelium tends to return to normal if the carcinogenic
stimulus is removed. However, not all simple, nodular,
FIGURE 14. Squamous cell carcinoma ofrat urinary bladder follow-
ing treatment with BBN. H&E, x 220.
and papillary hyperplasias regress, and when they per-
sist, they progress to more advanced lesions. In the
case ofsimple hyperplasia, two pathogenetic pathways
culminating in invasive transitional cell carcinoma have
been identified: (a)flat dysplasia with noninvasive car-
cinomas, and (b)nodularhyperplasia, polypoid inversed
papilloma, dysplasia, and polypoid noninvasive carci-
noma. Inthe case ofpapillary hyperplasia, the sequence
involves papilloma, dysplasia, andpapillarynoninvasive
carcinoma terminating in invasive carcinoma.
The pathogenesis ofhuman bladder cancer has many
parallelstothepatternintheratandhamster. Although
it is very likely that simple hyperplasia is a frequent
early lesion, it has only rarely been encountered for the
reasons cited earlier. However, the laterlesions, which
include papilloma, inverted papilloma, dysplasia, pap-
illary and nonpapillary noninvasive transitional cell car-
cinoma, and invasive carcinoma, have all been estab-
lished in man. Metaplasia of urothelium to squamous
epithelium due to sustained exposure to carcinogens
appears to be much more common in the rat (Fig. 14)
and hamster than in humans (Fig. 15) in the Western
World. In the Near East and other parts ofthe world,
onthe otherhand, whereinfestation oftheurinaryblad-
der by schistosomal parasites is widespread, squamous
metaplasia, squamous papilloma, and squamous carci-
noma ofthe bladder are frequently encountered.
Another, though much rarer, metaplastic variant en-
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Table 4. A comparison of lesions encountered during urinary
bladder carcinogenesis in the rat, hamster, and human.
Lesion Rat Hamster Human
Transitional cell
Simple hyperplasia + + ?
Nodular focal hyperplasia + + +
Papillary hyperplasia + Very rare +
Dysplasia ? ? +
Papilloma/papillary + - +
Transitional cell carcinoma
(Grade I-II)
Nodular TCC (Grade III-IV) + + +
Squamous metaplasia 2+ + +
Squamous cell differentiation 2-3+ 1-2+ +
Adenocarcinomatous variant - - Very rare
countered in man involves the conversion ofurothelium
to columnar cells that can be transformed to adenocar-
cinoma following chronic exposure to bladder carcino-
gens. Adenocarcinoma of the urinary bladder has not
been induced in the rat by any of the chemical carcin-
ogens that cause other bladder cancers in the species.
In the rodent urinary bladder, the histologic types of
lesions and their sequence culminating in transitional
cell carcinoma are quite similar ifnot identical to those
encountered in humans. These carcinogenic lesions are
summarized and compared to those that occur in the
human bladder in Table 4.
Conclusions
The morphology and sequence of proliferative, pre-
neoplastic, and neoplastic lesions seen during the ex-
perimental induction ofhepatocellular carcinoma in the
mouse and rat, ductal adenocarcinoma of the pancreas
in the hamster, and transitional cell carcinoma of the
urinary bladder in the rat and hamster bear a close
resemblance to those encountered in humans. Although
these qualitative features in some measure serve to val-
idate rodent models for bioassays of carcinogenesis,
other biological factors must be taken into account be-
fore carcinogenesis data gained from such studies can
be extrapolated to the estimation of human risk (22).
These other factors include the pharmacokinetics and
metabolism of the particular carcinogen in question,
which greatly affect the sensitivity of the host. While
itwouldbeidealtoknowallthedetailsoftheabsorption,
organ and tissue distribution, and metabolic handling
of carcinogens before testing them in animal bioassays
in order to draw valid conclusions about their potential
risk for humans, this is seldom the case. The situation
is further complicated by the antagonistic dialogue that
invariably ensues between federal regulatory agencies
and industry, goaded by the news media and concerned
citizens, when a chemical to which there is significant
human exposure is identified to be a potential human
carcinogen. These events often preclude the further de-
tailed studies needed to allow meaningful extrapolation
of animal bioassay data to humans. Until we learn how
to cope with these problems, it is important that reg-
ulatory decisions be based on impeccable experiments
and good science and are not a result of the pressures
of society or industry.
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